Literature DB >> 10813228

Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program.

G T Ferguson1, P L Enright, A S Buist, M W Higgins.   

Abstract

Chronic obstructive pulmonary disease (COPD) is easily detected in its preclinical phase using spirometry, and successful smoking cessation (a cost-effective intervention) prevents further disease progression. This consensus statement recommends the widespread use of office spirometry by primary-care providers for patients > or = 45 years old who smoke cigarettes. Discussion of the spirometry results with current smokers should be accompanied by strong advice to quit smoking and referral to local smoking cessation resources. Spirometry also is recommended for patients with respiratory symptoms such as chronic cough, episodic wheezing, and exertional dyspnea in order to detect airways obstruction due to asthma or COPD. Although diagnostic-quality spirometry may be used to detect COPD, we recommend the development, validation, and implementation of a new type of spirometry-office spirometry--for this purpose in the primary-care setting. In order to encourage the widespread use of office spirometers, their specifications differ somewhat from those for diagnostic spirometers, allowing lower instrument cost, smaller size, less effort to perform the test, improved ease of calibration checks, and an improved quality-assurance program.

Entities:  

Mesh:

Year:  2000        PMID: 10813228

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  10 in total

1.  Asthma and Allergic Disorders in Uganda: A Population-Based Study Across Urban and Rural Settings.

Authors:  Brooks W Morgan; Trishul Siddharthan; Matthew R Grigsby; Suzanne L Pollard; Robert Kalyesubula; Robert A Wise; Bruce Kirenga; William Checkley
Journal:  J Allergy Clin Immunol Pract       Date:  2018-02-01

Review 2.  Pharmacists performing quality spirometry testing: an evidence based review.

Authors:  Michael J Cawley; William J Warning
Journal:  Int J Clin Pharm       Date:  2015-07-07

3.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

Review 4.  What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Authors:  Nitin Y Bhatt; Karen L Wood
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme.

Authors:  Tuula Vasankari; Anne Pietinalho; Kalle Lertola; Seppo Yt Junnila; Kari Liippo
Journal:  BMC Fam Pract       Date:  2011-09-21       Impact factor: 2.497

6.  Pulmonary function of adolescents from Tripura, a North-eastern state of India.

Authors:  Dipayan Choudhuri; Balaram Sutradhar
Journal:  Lung India       Date:  2015 Jul-Aug

7.  Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document.

Authors:  E Bouza; A Alvar; P Almagro; T Alonso; J Ancochea; F Barbé; J Corbella; D Gracia; E Mascarós; J Melis; M Miravitlles; M Pastor; P Pérez; D Rudilla; A Torres; J B Soriano; A Vallano; F Vargas; E Palomo
Journal:  Rev Esp Quimioter       Date:  2020-01-14       Impact factor: 1.553

8.  Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan.

Authors:  Mousa Al Omari; Basheer Y Khassawneh; Yousef Khader; Ali Shakir Dauod; George Bergus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-07-17

9.  Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.

Authors:  Kyung Soo Chung; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Joo Han Song
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-19

10.  Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy.

Authors:  Ana Hernandez-Voth; Javier Sayas Catalan; Marta Corral Blanco; Alba Castaño Mendez; Miguel Angel Martin; Carlos De Fuenmayor Fernandez de la Hoz; Victoria Villena Garrido; Cristina Dominguez-Gonzalez
Journal:  BMJ Open Respir Res       Date:  2020-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.